Rolando Pajón

MedicineImmunology and MicrobiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial”.

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Cell Host & Microbe(2021)10.1016/j.chom.2021.03.002

N/A

10.9DataRank · unranked

395 citations

Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler +12 more

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine(2021)10.1056/nejmoa2113017

N/A

8.3DataRank · unranked

662 citations

Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson +33 more

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation

Scientific Reports(2021)10.1038/s41598-021-03154-6

N/A

3.8DataRank · unranked

80 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial

Frontiers in Immunology(2022)10.3389/fimmu.2021.798117

N/A

2.7DataRank · unranked

54 citations

Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Udo Eichenlaub +3 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial

medRxiv(2021)10.1101/2021.10.04.21264521

N/A

0.877DataRank · unranked

14 citations

Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Udo Eichenlaub +3 more

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac188

N/A

0.686DataRank · unranked

21 citations

Lindsey R. Baden, Brandon Essink, David C. Montefiori, Adrian McDermont, Richard Rupp +19 more

Mapping SARS-CoV-2 antigenic relationships and serological responses

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.28.477987

N/A

0DataRank · unranked

67 citations

Barbara Mühlemann, Xiaoying Shen, Sina Türeli, Eric B. LeGresley, Antonia Netzl +27 more

Mapping SARS-CoV-2 antigenic relationships and serological responses

Science(2023)10.1126/science.adj0070

N/A

0DataRank · unranked

135 citations

Barbara Mühlemann, Xiaoying Shen, Sina Türeli, Eric B. LeGresley, Antonia Netzl +27 more

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad069

N/A

0DataRank · unranked

10 citations

Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy +19 more

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

Journal of Virology(2021)10.1128/jvi.01313-21

N/A

0DataRank · unranked

116 citations

Matthew Koch, Kaichun Wu, Groves Dixon, Judy Oestreicher, Holly Legault +7 more

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization

medRxiv(2021)10.1101/2021.12.15.21267805

N/A

0DataRank · unranked

129 citations

Xiaoying Shen, Stephen D. Schmidt, Sijy O’Dell, Charlene McDanal, Wenhong Feng +31 more

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.27.428516

N/A

0DataRank · unranked

79 citations

Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler +13 more

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.28.449914

N/A

0DataRank · unranked

28 citations

Matthew Koch, Kaichun Wu, Groves Dixon, Judy Oestreicher, Holly Legault +7 more

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Research Square(2021)10.21203/rs.3.rs-862572/v1

N/A

0DataRank · unranked

10 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

medRxiv(2021)10.1101/2021.09.09.21263049

N/A

0DataRank · unranked

2 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials

Clinical Infectious Diseases(2022)10.1093/cid/ciac780

N/A

0DataRank · unranked

7 citations

Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kashif Ali, Gary Berman +10 more